The Safety Pharmacology Society (SPS) is an organization that focuses on safety pharmacology.[1]
| Formation | 2000 |
|---|---|
| Headquarters | Reston, Virginia |
Official language | English |
Current president | Marie-Luce Rosseels |
| Website | Official website |
History
editThe Safety Pharmacology Society was incorporated in 2000,[2] at the time when the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use was issuing ICH S7A, a regulatory guidance covering safety pharmacology, and drafting ICH S7B, which is more specific to potential effects of new drugs on cardiac repolarization.[3]
The Safety Pharmacology Society organizes an annual meeting in the fall, comprising invited speakers and posters.[4] This meeting has alternated between North America and Europe.
References
edit- ^ "Safety Pharmacology Society". safetypharmacology.org. Retrieved 10 March 2024.
- ^ Safety Pharmacology Society (SPS). "History of Safety Pharmacology [TIMELINE]" (PDF). Retrieved 17 August 2022.
- ^ "ICH Harmonised Tripartite Guideline for Safety Pharmacology Studies for Human Use". 8 November 2000. ICH S7B.
- ^ Redfern WS, Valentin J-P (2011). Trends in safety pharmacology: Posters presented at the annual meetings of the Safety Pharmacology Society 2001–2010. J Pharmacol. Toxicol. Methods 64: 102–110.